Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 10 Pain, Postoperative 9 Neoplasms 9 Parkinson Disease 4, Autosomal Dominant Lewy Body 8 Lung Neoplasms 8 Stomach Neoplasms 6 Colonic Neoplasms 6 Brain Neoplasms 6 Thyroid Neoplasms 5 Prostatic Neoplasms 5 Colorectal Neoplasms 5 Agnosia 4 Thromboembolism 3 Pain 3 Ovarian Neoplasms 3 Myofibroma 3 Head and Neck Neoplasms 3 Depression 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Uterine Neoplasms 2 Urinary Bladder Neoplasms 2 Supratentorial Neoplasms 2 Neoplasm Metastasis 2 Leiomyoma 2 Hemangioma 2 Arthritis, Rheumatoid 2 Vomiting 1 Visceral Pain 1 Uterine Cervical Neoplasms 1

Interventions

Tranexamic Acid 6 Sodium Chloride 2 Ringer's Lactate 2 maleimide-polyethylene glycol-modified hemoglobin, MP4 1 bemiparin 1 Uterine Artery Embolization 1 Tourniquets 1 Sutures 1 Surgicel 1 Saline Solution 1 Rivaroxaban 1 Ringer's Solution 1 Pancreaticoduodenectomy 1 Mannitol 1 Lenalidomide 1 Ibuprofen 1 Goserelin 1 Gonadotropin-Releasing Hormone 1 Furosemide 1 FloSeal Matrix 1 Esomeprazole 1 Data Collection 1 Dalteparin 1 Crystalloid Solutions 1 Colloids 1 Blood Transfusion 1 Bevacizumab 1 Aspirin 1 Arginine Vasopressin 1 Arginine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hemorrhage × Saline Solution × Clear all

NCT02620748 2022-10-13

TA

George Washington University

Phase 1 Completed

Hemorrhage, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡